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Peroxiredoxins decompose peroxides through reversible oxidation of their active site cysteines. The
redox state of the 2-Cys peroxiredoxins, 1, 2 and 3, was investigated in mouse hearts undergoing
ischemia and reperfusion in a Langendorff system. The peroxiredoxins were predominantly reduced
in control hearts. Mitochondrial peroxiredoxin 3 underwent signiﬁcant oxidation to its disulﬁde-
linked dimer during ischemia. Oxidation was largely reversed during reperfusion. No redox changes
in cytoplasmic peroxiredoxins 1 and 2 were apparent. Peroxiredoxin 3 oxidation suggests localized
mitochondrial generation of reactive oxidants during ischemia. This local antioxidant activity of
peroxiredoxin 3 may have a role in maintaining cardiac function.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Peroxiredoxins (Prxs) are a ubiquitous family of thiol-based
antioxidant proteins that are involved in controlling cellular perox-
ide levels and in redox regulation of signal transduction [1–3].
There are six members of the mammalian Prx family (Prx 1–6),
grouped as typical 2-Cys, atypical 2-Cys, and 1-Cys Prxs. This study
focuses on the typical 2-Cys Prxs, Prx1 and Prx2 which are cyto-
solic, and Prx3 which is strictly localized to mitochondria [2]. These
proteins react rapidly with hydrogen peroxide (H2O2) and other
peroxides [2,4]. In this reaction, the active site sulfhydryl group
(Cys-SH) on one subunit is oxidized to the sulfenic acid (Cys-
SOH) which reacts with a neighboring Cys-SH on another subunit
to generate a disulﬁde-linked homodimer. The disulﬁde is reduced
by thioredoxin, which is regenerated by thioredoxin reductase and
NADPH [3]. Prxs can also become hyperoxidized to the sulﬁnic
acid, in a process that is slowly reversed by sulﬁredoxins. Prxs
are highly abundant in heart [5] and are attracting increasing inter-
est as important factors in the cardiac response to oxidative stress.
Ischemia/reperfusion injury is a major contributor to coronary
artery disease. It is associated with mitochondrial dysfunction, cal-
cium accumulation and the generation of reactive oxygen or nitro-
gen species [6]. Prolonged ischemia leads to loss of viability of
myocardial cells, and while reperfusion is necessary to reversechemical Societies. Published by E
(C.C. Winterbourn).changes induced by ischemia, it is associated with a second wave
of tissue injury and contractile impairment. Reperfusion results
in a burst of reactive oxygen species (ROS) production as oxygen
re-enters the heart [7]. Increased ROS production can also arise
during ischemia in association with injury to the myocyte mito-
chondrial electron transport chain [8], and has been shown to
prime cardiomyocytes for subsequent reperfusion injury [9].
Thiol proteins are vulnerable targets for ROS [10]. Cardiac pro-
teins involved in excitation-contraction coupling such as SERCA
and ryanodyne receptor as well as signaling proteins are oxidant-
sensitive [11]. Proteomic analysis of cardiomyocytes or hearts sub-
jected to oxidative stress or ischemia/reperfusion has also detected
thiol redox changes [12,13]. In view of their high reactivity with
peroxides, 2-Cys Prxs should be among the most sensitive thiol
protein targets for ROS generated during ischemia/reperfusion
and could act as protective antioxidants or redox sensors in the
ischemic heart. In this study we have investigated redox changes
in Prx1, Prx2 and Prx3 during ischemia and/or reperfusion in a
mouse heart Langendorff perfusion system.
2. Materials and methods
2.1. Material and reagents
N-ethylmaleimide (NEM), Igepal CA-630 (equivalent to Nonidet
P-40) and Tween-20 were purchased from Sigma–Aldrich (St Louis,
MO). Rabbit polyclonal antibodies to Prx1 and Prx2 were suppliedlsevier B.V. All rights reserved.
Fig. 1. Effect of NEM blocking during sample preparation on the redox state of
peroxiredoxin 2. Non-reducing immunoblots of whole mouse heart extracts were
probed with a polyclonal antibody against Prx2 and show 22 kDa monomer and
44 kDa disulﬁde-bonded dimer bands. Lane 1, NEM added during extraction; lane 2,
heart immersed in PBS containing NEM but no NEM added during extraction; lane
3, no NEM added; and lane 4, heart immersed in PBS containing NEM and NEM
present in extraction buffer.
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from AbFrontier (Seoul, Korea). Goat antirabbit horseradish
peroxidase was from Sigma. Polyvinylidene diﬂuoride membrane
and enhanced chemiluminescence reagents were supplied by
Amersham Biosciences (Buckinghamshire, United Kingdom).
2.2. Ischemia/reperfusion in isolated mouse hearts
Hearts were rapidly excised from CD-1 mice killed by lethal
injection of pentobarbital (according to an ethically approved pro-
tocol), mounted on the Langendorff apparatus and retrogradely
perfused with modiﬁed Tyrode solution gassed with O2. Control
hearts (C) were perfused brieﬂy to remove blood. After 2 min sta-
bilization, experimental hearts were either subjected to 30 min
control perfusion (CP), or 20 min global ischemia (I) by stopping
the coronary ﬂow. Coronary perfusion was then restored for
5 min (IR5) or 30 min (IR30) min. There were seven hearts in each
group. After perfusion the hearts were quickly immersed into PBS
containing 100 mM NEM for 5 min and then snap frozen in liquid
nitrogen and stored at 80 C.
For protein extraction, each frozen heart was placed in NP-40
lysis buffer (50 mM Tris–HCl pH 8, 137 mM NaCl, 10% glycerol,
1% NP-40, 2 mM EDTA) containing 100 mM NEM and complete
protease inhibitor cocktail (Roche, Mannheim, Germany) at
300 ll per 5 mg of tissue. The tissue was homogenized using a
glass hand homogenizer then left on a rotator for 2 h at 4 C before
centrifugation at 12000 rpm for 20 min at 4 C. The supernatant
was aspirated, its protein content measured using the Bio-Rad as-
say, and aliquots were stored at 80 C.
2.3. Western blot analysis
Proteins (30 lg) from mouse heart extract were resolved by
non-reducing 12% SDS–PAGE and then transferred to a polyvinyli-
dene diﬂuoride (PVDF) membrane. The membranes were blocked
using 5% non-fat dried milk in Tris–buffered saline with 0.2%
Tween, then treated in the same buffer at 4 C overnight with pri-
mary antibodies to Prx1, Prx2 and Prx3, diluted according to man-
ufacturer’s instructions. Bands were detected with goat-antirabbit
horseradish peroxidase using enhanced chemiluminescence re-
agents, and visualized with the ChemiDoc XRS gel documentation
system (Bio-Rad, Segrate, Italy). Band intensities were quantiﬁed
with Quantity One software (Bio-Rad, Hercules, CA).Fig. 2. Effect of ischemia and/or reperfusion on the redox state of peroxiredoxin 3.
Non-reducing (A) and reducing (C) immunoblots of whole mouse heart extract
probed with polyclonal antibody against Prx3. Lanes represent control (C), control
perfusion (CP), ischemia (I), and ischemia and reperfusion for 5 min (IR5) or 30 min
(IR30). (B) Shows combined data (seven hearts in each group) for percentages of
dimer from densitometry scans, where each immunoblot was done in duplicate.
Results are means ± SEM; *signiﬁcantly different from other treatments (P < 0.05)
by repeated measures one way analysis of variance (ANOVA) using SigmaStat 3.1.3. Results
Before investigating changes during ischemia/reperfusion, we
established the redox state of the native Prxs within the heart. Prxs
are extremely sensitive to oxidation during isolation [4] and this
can be avoided by blocking reduced cysteines with NEM. To opti-
mize this procedure, control hearts were extracted with 100 mM
NEM added at different stages. Samples were resolved by non-
reducing SDS–PAGE, in which the reduced Prxs run as 22–25 kDa
monomers and the oxidized forms as dimers. Blotting for Prx2
showed that with NEM added only to the lysis buffer, the protein
was partially dimerized (Fig. 1, lane 1). When the heart was soaked
in NEM but no NEM added to the lysis buffer, most of the Prx2 was
present as the dimer (lane 2) and with no NEM added at any stage
it was completely dimerized (lane 3). However, with NEM added to
the intact heart and the lysis buffer, the majority of the Prx2 was
monomeric (lane 4). Each sample gave only a monomeric Prx2
band on a reducing gel (not shown), indicating that dimerization
was fully reversible. From this we conclude that Prx2 at steady
state in the heart is predominantly reduced, and great care is
needed to avoid oxidation during tissue isolation.The redox state of the Prxs was studied in hearts subjected to
ischemia/reperfusion using a Langendorff system. Samples were
taken after the ischemia period and after 5 and 30 min reperfusion
to investigate early and longer term changes, respectively. Results
were compared with those from untreated and control perfused
hearts. Immunoblots revealed changes in Prx3. As shown for one
set of samples in Fig. 2A and the combined densitometry data in
Fig. 2B, the majority of Prx3 was reduced in control hearts. There
was a signiﬁcant increase in the amount of dimer present after
ischemia (P < 0.001 compared with the other treatments) and this
decreased early in the reperfusion period. A possible increase at
30 min reperfusion did not reach signiﬁcance. Dimerization was
reversed with dithiothreitol, conﬁrming formation of disulﬁde-
linked intermolecular dimers (Fig. 2C).
Fig. 3. Effect of ischemia and/or reperfusion on the redox state of peroxiredoxins 1
and 2. Representative non-reducing immunoblots of mouse heart extract probed
with polyclonal antibody against Prx1 (A) and Prx2 (C) and combined densitometry
scans for seven mouse hearts in each group (B) and (D) where each immunoblot
was done in duplicate. Lane labels and data representation are as in Fig 2. There
were no signiﬁcant differences between any of the treatments.
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dimerization of the Prx1 (Fig. 3B) or Prx2 (Fig. 3D). It is possible
that they could have undergone oxidation to the hyperoxidized
(sulﬁnic acid) form rather than the disulﬁde, which would not be
detected by this method. This possibility was eliminated by blot-
ting with an antibody to the sulﬁnic acid forms of the Prxs. The
antibody recognizes Prxs 1, 2 and 3 and detected no hyperoxida-
tion during any of the treatments (data not shown). As a control,
Jurkat cells treated with H2O2, which causes Prx hyperoxidation,
gave a positive band.
4. Discussion
Peroxiredoxins are now recognized as important components of
cellular antioxidant defence, and the evidence from overexpression
and knockout studies with Prx3 [14], Prx2 [15] and Prx6 [16] indi-
cates that they are important for maintaining cardiac function.
Intracellular Prx oxidation and recycling by the thioredoxin/thiore-
doxin reductase system could play a vital antioxidant role duringcardiac ischemia/reperfusion by preventing oxidative injury to
other critical molecules. We therefore investigated whether ROS
generation during ischemia and/or reperfusion in mouse heart re-
sults in oxidation of 2-Cys Prxs.
Initial examination of freshly isolated heart revealed that the
Prxs exist predominately in a reduced form, but are prone to oxida-
tion during isolation. Ex vivo oxidation was minimized by treating
the heart with NEM before as well as during tissue extraction.
Without such treatment, oxidation during isolation could confound
interpretation of experiments investigating changes in Prx oxida-
tion state. For example, it could have contributed to the high levels
of Prx dimers reported by Schroder et al. [5] for control rat hearts.
Some dimer would be expected due to ongoing redox cycling, with
the dimer to monomer ratio reﬂecting the difference in rates of
oxidation by endogenous oxidants and reduction by thioredoxin
reductase/thioredoxin/NADPH. Our data suggests a balance in
favor of the reduced form.
With ischemia/reperfusion, we observed signiﬁcant oxidation of
Prx3 to the disulﬁde, but no changes in the cytoplasmic Prxs. No
hyperoxidation was evident. Our ﬁndings are indicative of oxida-
tive stress in the mitochondrial matrix and consistent with
increased mitochondrial ROS production or alternatively, a
decreased capacity to recycle Prx3 via the mitochondrial thiore-
doxin reducatse/thioredoxin/NADPH system. The selective oxida-
tion of Prx3 contrasts with the extensive Prx oxidation that
others have observed with H2O2. Perfusion of rat hearts with
10–100 lM H2O2 caused substantial dimerization of all the 2-Cys
Prxs and at the higher concentrations, hyperoxidation [5]. Hyper-
oxidation was also seen in H2O2-treated cardiomyocytes [17]. It
is worth noting that although the H2O2 concentrations used seem
low, the amounts present in perfusate or culture medium are much
greater of than would be generated endogenously. Therefore,
caution is needed in extrapolating results with added oxidant to
ischemia/reperfusion. Furthermore, the addition of H2O2 to the
perfusate does not mimic the naturally occurring gradient of ROS
which should be directed from mitochondria to the cytoplasm.
There is substantial evidence for excessive production of mito-
chondrial oxidants in reperfusion injury [7,18–20]. It was surpris-
ing, therefore, to observe that most of the Prx3 oxidation
occurred during ischemia and was reversed within 5 min reperfu-
sion. The prevailing view is that the main burst of ROS production
occurs at the start of reperfusion, when oxygen becomes available
to cells that have been compromised during the ischemic period
[8,17,21,22]. However, others have detected leakage of reactive
oxidants from mitochondria [8] and reversible oxidation of an
intracellular thiol probe [9] during cardiac ischemia. It was specu-
lated that oxidation occurs before oxygen is fully depleted, during
a period of hypoxia when the electron transport chain is more
leaky [8]. Decreased mitochondrial ROS production following
return to normal oxygenation could explain the reversal of Prx3
oxidation in our model. Alternatively, the ability of the mitochon-
dria to reduce Prx3 could be decreased during ischemia. This
depends ultimately on availability of NADPH. The mitochondrial
NADPH/NADP ratio is partially set by the action of the transhydro-
genase, which is reliant on the mitochondrial membrane potential
[23]. If the mitochondria were to become energized during
ischemia, NADPH could be depleted. Reperfusion could reverse
these changes and restore their reducing capacity.
Although ischemia and/or reperfusion did not cause Prx1 or
Prx2 dimerization, redox cycling of these forms could still have
increased, provided the reducing capacity of the cytoplasmic
thioredoxin/thioredoxin reductase system was sufﬁcient to keep
up with enhanced oxidation. Hyperoxidation is proposed to occur
during redox cycling, with a small proportion of the sulfenic acid
form of the Prx becoming further oxidized before it can dimerize
[1]. The absence of cytoplasmic Prx hyperoxidation in this study
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of H2O2 to dramatically increase turnover. In connection with this
point, the selective oxidation of Prx3 at the site of metabolic
oxidant formation could be viewed as a protective system for
cytoplasmic proteins.
Our ﬁnding imply that Prx3 dimerization could be a sensitive
indicator of mitochondrial ROS production and highlight a poten-
tial use of Prxs as sensors. Sensors have been developed using thiol
peptides derived from oxyR or HSP-33 coupled to probes that
undergo a ﬂuorescence change when the thiols are oxidized to
disulﬁdes [9,24]. The 2-Cys peroxiredoxins are more reactive with
H2O2 than these sensors [4], and have the additional beneﬁt of
being already present in cells without requiring an expression
system.Acknowledgment
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